awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30666276-B5E9B841-B870-439C-B387-82819114227A
Q30666276-B5E9B841-B870-439C-B387-82819114227A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30666276-B5E9B841-B870-439C-B387-82819114227A
Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistance
P2860
Q30666276-B5E9B841-B870-439C-B387-82819114227A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30666276-B5E9B841-B870-439C-B387-82819114227A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f62a0944653aa6c0cb5aa4567765e6406f8f028c
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.